The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway

Nature Immunology

Volumn 6, Issue 4, 2005, Pages 396-402

  Salvador, Jesus M ^a,b   Mittelstadt, Paul R ^a   Belova, Galina I ^a   Fornace Jr , Albert J ^a,c   Ashwell, Jonathan D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE ZAP 70; CELL CYCLE PROTEIN; GADD45A PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; NUCLEAR PROTEIN; PROTEIN TYROSINE KINASE; TYROSINE; ZAP70 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; LUPUS VULGARIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE PROTEINS; ENZYME ACTIVATION; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TYROSINE; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 16844366591     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1176     Document Type: Article

References (42)

1. Fan, W., Richter, G., Cereseto, A., Beadling, C. & Smith, K.A. Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18, 6573-6582 (1999).
2. Fornace, A.J., Jr. et al. Mammalian genes coordinately regulate by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9, 4196-4203 (1989).
3. WAF1/CIP1. Oncogene 12, 2579-2594 (1996).
4. H1 cells. Immunity 14, 583-590 (2001).
5. Yang, J., Zhu, H., Murphy, T.L., Ouyang, W. & Murphy, K.M. IL-18-stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2, 157-164 (2001).
6. Lu, B., Ferrandino, A.F. & Flavell, R.A. Gadd45β is important for perpetuating cognate and inflammatory signals in T cells. Nat. Immunol. 5, 38-44 (2004).
7. Hoffmeyer, A., Piekorz, R., Moriggl, R. & Ihle, J.N. Gadd45γ is dispensable for normal mouse development and T-cell proliferation. Mol. Cell. Biol. 21, 3137-3143 (2001).
8. Hollander, M.C. et al. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23, 176-184 (1999).
9. Hollander, M.C. et al. Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res. 61, 2487-2491 (2001).
10. Salvador, J.M. et al. Mice lacking the p53-Eefector gene Gadd45a develop a lupus-like syndrome. Immunity 16, 499-508 (2002).
11. Rincon, M. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13, 339-345 (2001).
12. Salvador, J.M. et al. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat. Immunol. advance online publication, 27 February 2005 (doi:10.1038/ni1177).
13. Takekawa, M. & Saito, H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95, 521-530 (1998).
14. Mita, H., Tsutsui, J., Takekawa, M., Witten, E.A. & Saito, H. Regulation of MTK1/ MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol. Cell. Biol. 22, 4544-4555 (2002).
15. Chi, H., Lu, B., Takekawa, M., Davis, R.J. & Flavell, R.A. GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNγ production in T cells. EMBO J. 23, 1576-1586 (2004).
16. 2-terminal kinase (Jnk) gene expression during T cell activation. J. Exp. Med. 191, 139-146 (2000).
17. Dong, C., Davis, R.J. & Flavell, R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72 (2002).
18. Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37-40 (2001).
19. Giroux, S. et al. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr. Biol. 9, 369-372 (1999).
20. Alberola-Ila, J., Forbush, K.A., Seger, R., Krebs, E.G. & Perlmutter, R.M. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373, 620-623 (1995).
21. Pagès, G. et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374-1377 (1999).
22. Bulavin, D.V., Kovalsky, O., Hollander, M.C. & Fornace, A.J.J. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol. Cell. Biol. 23, 3859-3871 (2003).
23. Schaeffer, H.J. & Weber, M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444 (1999).
24. Dong, C. et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94 (2000).
25. Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 (2000).
26. Brancho, D. et al. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17, 1969-1978 (2003).
27. Tanaka, N. et al. Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis. EMBO Rep. 3, 785-791 (2002).
28. Wang, X.S. et al. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272, 23668-23674 (1997).
29. Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011 (1995).
30. Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94 (1997).
31. Wang, X.S. et al. Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase kinase kinase. J. Biol. Chem. 271, 31607-31611 (1996).
32. Ge, B. et al. MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α. Science 295, 1291-1294 (2002).
33. Hildesheim, J. et al. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62, 7305-7315 (2002).
34. Gong, Q. et al. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat. Immunol. 2, 29-36 (2001).
35. Ward, S.G., Parry, R.V., Matthews, J. & O'Neill, L. A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production. Biochem. Soc. Trans. 25, 304S (1997).
36. Matsuda, S., Moriguchi, T., Koyasu, S. & Nishida, E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273, 12378-12382 (1998).
37. Zhang, J. et al. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162, 3819-3829 (1999).
38. Haeryfar, S.M. & Hoskin, D.W. Selective pharmacological inhibitors reveal differences between Thy-1- and T cell receptor-mediated signal transduction in mouse T lymphocytes. Int. Immunopharmacol. 1, 689-698 (2001).
39. Allison, A.C. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 47, 63-83 (2000).
40. Lee, J.C. et al. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47, 185-201 (2000).
41. Kovalsky, O., Lung, F.D., Roller, P.P. & Fornace, A.J.J. Oligomerization of human Gadd45a protein. J. Biol. Chem. 276, 39330-39339 (2001).
42. Zhan, Q. et al. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18, 2892-2900 (1999).